148 -5 (79) 2025 - Juraeva D.E., Matkarimova D.S. - ANALYSIS OF THE DETECTION STATUS OF PRIMARY IMMUNE THROMBOCYTOPENIA IN THE SURKHANDARYA REGION

ANALYSIS OF THE DETECTION STATUS OF PRIMARY IMMUNE THROMBOCYTOPENIA IN THE SURKHANDARYA REGION

Juraeva D.E. - Termez branch of the Tashkent Medical Academy, Tashkent Medical Academy

Matkarimova D.S. - Termez branch of the Tashkent Medical Academy, Tashkent Medical Academy

Resume

Objective: To investigate the detection status of primary immune thrombocytopenia in the Surkhandarya region. Materials and methods: The research material consisted of data from the analysis of medical records of patients diagnosed with ITP in medical institutions of the Surkhandarya region from 2012 to 2024. Methods included clinical, laboratory, morphological, and statistical studies. Results: Based on a retrospective analysis to assess the status of primary detection of ITP among the adult population of the Surkhandarya region, we identified an unsatisfactory state of hematological services associated with a shortage of hematologists in the region's primary healthcare system.

Keywords: immune thrombocytopenia, detection, Surkhandarya region, age category, gender characteristics.

First page

741

Last page

744

For citation:Juraeva D.E., Matkarimova D.S. - ANALYSIS OF THE DETECTION STATUS OF PRIMARY IMMUNE THROMBOCYTOPENIA IN THE SURKHANDARYA REGION//New Day in Medicine 5(79)2025 741-744 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

1. Isaeva B.E. Clinical and epidemiological characteristics of thrombocytopenic purpura in children in Kyrgyzstan // Modern problems of science and education. - 2016. - No. 3.
2. Matkarimova D.S., Djuraeva D.E., Nabieva M.I. General overview and state of the problem of immune thrombocytopenia prevalence. // Journal of Humanities and Natural Sciences. No. 5 (11), 2023.
3. Melikyan A.L. et al. Interim results of an epidemiological study of idiopathic thrombocytopenic purpura in adults in the Russian Federation. Hematology and Transfusiology. 2019;64 (4):436-446.
4. Bussel J. et al. Immune thrombocytopenia // Expert review of hematology. - 2021. - Vol. 14. - No. 11. - P. 1013-1025.
5. Djuraeva D.E., Matkarimova D.S., Boboev K.T. Genes of the Integrin Family of Platelet Receptors (ITGA2 (C807T) and ITGβ3 (T1565C)): Features of Distribution and Analysis of the Role in Immune Thrombocytopenia // American Journal of Medicine and Medical Sciences 2025, 15 (2): 346-350.
6. Ito S. et al. Evaluation of thrombotic events in patients with immune thrombocytopenia // Annals of hematology. - 2020. - Vol. 99. - P. 49-55.
7. Kohli R., Chaturvedi S. Epidemiology and clinical manifestations of immune thrombocytopenia // Hämostaseologie. - 2019. - Vol. 39. - No. 03. - P. 238-249.
8. Machin N. et al. Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: an NIS study // Thrombosis Research. - 2018. - Vol. 172. - P. 80-85.
9. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3 (22):3780-3817.
10. Schmidt D. E. et al. Anti-platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications // Journal of Thrombosis and Haemostasis. - 2020. - Vol. 18. - No. 5. - P. 1210-1220.
11. Shaw J. et al. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States // Platelets. - 2020. - Vol. 31. - No. 3. - P. 307-314.
12. Zhang Y. et al. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19 // Thrombosis research. - 2020. - Vol. 193. - P. 110-115.

    file

    download